Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04766177
PHASE3
Role of Bumetanide in Treatment of Autism
Sponsor: Sherief Abd-Elsalam
View on ClinicalTrials.gov
Summary
Role of bumetanide in Autism
Official title: Role of Bumetanide in Treatment of Autism Spectrum Disorder in Children
Key Details
Gender
All
Age Range
3 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2021-01-01
Completion Date
2030-12-01
Last Updated
2021-02-23
Healthy Volunteers
No
Conditions
Interventions
DRUG
Bumetanide
bumetanide 0.5 mg twice daily
DRUG
Placebo
placebo tablets twice daily
Locations (1)
Sherief Abd-Elsalam
Tanta, Egypt